Abstract
BackgroundIn this retrospective study, we studied the impact of educational osteoporosis program on the rates of bone mineral density (BMD) assessment and bone turnover markers (BTM) and drug medications in the patients with hip fracture.MethodsThis retrospective research enrolled 651 patients aged ≥50 years who experienced hip fractures from January 2013 to December 2015. We recorded whether patients had received BMD assessment, BTM measurement, and anti-osteoporosis therapy during the period of hospitalization. Orthopedic surgeons were classified into the trained group and the untrained group. The rates of BMD assessment, BTM measurement, and anti-osteoporosis medications in the patients with hip fracture were compared between the trained group and the untrained group.ResultsBMD assessment was performed in 109/220 patients in the trained group and 142/431 patients in the untrained group. BTM measurements were performed in 130 patients in the trained group and 124 patients in the untrained group. Forty eight patients in the trained group and 63 patients in the untrained group received bisphosphonate medications.ConclusionsAlthough the rates of BMD assessment, BTM measurement, and bisphosphonate use in the patients after hip fractures are still insufficient, education programs help to improve the situation.
Highlights
Osteoporosis is very common in the elderly, and the consequences of fractures caused by osteoporosis are very serious
The rate of zoledronate use in the trained group was significantly higher than that in the untrained group (p < 0.05) (Table 2). This retrospective study confirmed that the rates of Bone mineral density (BMD) assessment and bone turnover markers (BTM) measurement were 38.6 and 39.0%, respectively, in the patients with hip fracture
The patients in the trained group of orthopedic surgeons had higher rates of BMD assessment and BTM measurement than the patients in the untrained group (49.5% vs 32.9% for BMD assessment and 59.0% vs 28.8% for BTM measurement)
Summary
Osteoporosis is very common in the elderly, and the consequences of fractures caused by osteoporosis are very serious. Hip fragility fractures are a common and serious complication of osteoporosis, which is associated with a high risk of fracture and mortality in the future [1,2]. Several studies confirm that anti-osteoporosis medications can reduce the risk of future fractures and the mortality after hip fracture [5,6,7]. Recent study suggested that the rates of BMD assessment and anti-osteoporotic therapy after hip fracture increased 2-fold after active participation of orthopedic surgeons in the treatment of osteoporosis [10]. In order to see the influence of orthopedic surgeon’s awareness on the diagnosis and treatment of osteoporosis, this retrospective study compared the rates of BMD assessment, bone turnover markers (BTM), and drug medications in the patients with hip fracture between the trained orthopedic surgeons and untrained orthopedic surgeons in the same hospital
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
